In the fast-evolving world of medical devices, efficiency is the bridge that connects innovation to patient care. Every technological advancement (whether diagnostic, therapeutic, or monitoring) only fulfills its purpose when it reaches the healthcare system and, ultimately, the patient who needs it most.
Between the development of a technology and its arrival in the Brazilian market lies a complex journey: regulatory approvals, tax barriers, logistical challenges, and hospital integration. This is where Brisa Advisors operates (making the process faster, more predictable, and more sustainable).
Efficiency as the Foundation of Market Access
In the context of market access, efficiency means much more than speed. It’s about structure, planning, and integration. A medical device only reaches the patient at the right time when every step (regulatory, fiscal, logistical, and commercial) is strategically aligned.
At Brisa Advisors, we have built a collaborative market access ecosystem that serves as a single coordination point for international manufacturers. Our model combines technical precision, strategic insight, and solid partnerships with key healthcare stakeholders.
The Brisa Advisors Ecosystem
Our ecosystem was designed to eliminate barriers and accelerate results. It is structured around four fundamental and interconnected pillars:
- Regulation and Local Representation (ANVISA):Â We ensure full compliance and predictability at every stage of the registration process.
- Tax and Structural Optimization: We reduce import and commercialization costs, enhancing the competitiveness of our clients’ products in the Brazilian market.
- Distribution and Hospital Integration:Â We connect international manufacturers directly with hospitals and healthcare networks through efficient and reliable logistics.
- Strategic Partnerships:Â We collaborate with leading industry players to create a high performing, innovation driven environment.
The result is a coordinated and transparent flow, where each stage reinforces the other (reducing timelines and expanding access to advanced healthcare technologies in Brazil).
Efficiency That Creates Real Impact
Efficiency is not just an operational advantage (it’s a social responsibility). Every faster approval means a patient treated sooner, a therapy started earlier, a life transformed.
That’s why we believe regulatory efficiency and strategic collaboration are the keys to shortening the distance between innovation and the patient. When the process operates in an integrated and coordinated way, everyone benefits: manufacturers reduce costs and risks, healthcare systems gain access to innovation, and patients receive faster, safer care.
An Invitation to Collaborate
The future of the medical device industry depends on collaborative market access models that combine technical expertise, regulatory intelligence, and a shared commitment to social impact.
At Brisa Advisors, we are ready to build that future (with efficiency, transparency, and purpose).
Would you like to accelerate your medical device’s access to the Brazilian market? Contact our team and schedule a virtual meeting. Together, we’ll design the right strategy to bring your innovation closer to patients (efficiently and sustainably).
Brisa Advisors: Connecting global innovation to the Brazilian market
Find out more about BPO in RA!
*Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br
